BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Lung
,
Laser capture microdissection
,
Fluoxetine
,
rs3825942
,
EGFR
,
Angiogenesis
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
dystroglycans
(compound)
Summary
General Info
Genetic Markers
Most Correlated Genes
No genes found
Explore Genetic Markers Results
Pathway Enrichment
Most Correlated Biogroups
No biogroups found
Explore Pathway Enrichment Results
Curated Studies
Most Correlated Studies
OMIM - Muscular dystrophy
Adult skeletal muscle from embryonic or postnatal Galgt2 overexpression in mdx or healthy mice
Tibialis anterior muscle regeneration in FKRP mutant mice following notexin treatment
Explore Curated Studies Results
Literature
Most Relevant Literature
The many roles of dystroglycan in nervous system development and function: Dystroglycan and neural c…
Inhibitory machinery for the functional dystroglycan glycosylation.
A combinatorial code of neurexin-3 alternative splicing controls inhibitory synapses via a trans-syn…
Neuronal Dystroglycan regulates postnatal development of CCK/cannabinoid receptor-1 interneurons.
Exocyst-mediated membrane trafficking of the lissencephaly-associated ECM receptor dystroglycan is r…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Clinical Trial Readiness for the Dystroglycanopathies
Congenital Muscle Disease Study of Patient and Family Reported Medical Information
Intravenous Immune Globulin to Treat Hereditary Inclusion Body Myopathy
Open Label Phase 2 Study of BBP-418 in Patients With LGMD2I
Biomarker Development in LGMD2i
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ